XBI
$114.01
SPDR(R) S&P(R) Biotech ETF
Fund Family: Unknown
Explore sections
1 Month
+8.30%
YTD
+13.45%
1 Year
+13.45%
3 Year
+35.85%
Top 10 Holdings (28.7% of portfolio)
- State Street Global AdvisorsUnknown6.17%
- Alnylam Pharmaceuticals IncUnknown2.66%
- Exelixis IncUnknown2.59%
- United Therapeutics CorpUnknown2.53%
- Insmed IncUnknown2.50%
- Gilead Sciences IncUnknown2.47%
- Natera IncUnknown2.47%
- Regeneron Pharmaceuticals In…Unknown2.46%
- Neurocrine Biosciences IncUnknown2.46%
- Moderna IncUnknown2.42%
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | State Street Global Advisors | GVMXX | Unknown | 6.17% |
| 2 | Alnylam Pharmaceuticals Inc | ALNY | Unknown | 2.66% |
| 3 | Exelixis Inc | EX9 | Unknown | 2.59% |
| 4 | United Therapeutics Corp | UTH | Unknown | 2.53% |
| 5 | Insmed Inc | IM8N | Unknown | 2.50% |
| 6 | Gilead Sciences Inc | GILD | Unknown | 2.47% |
| 7 | Natera Inc | NTRA | Unknown | 2.47% |
| 8 | Regeneron Pharmaceuticals Inc | REGN | Unknown | 2.46% |
| 9 | Neurocrine Biosciences Inc | NBIX | Unknown | 2.46% |
| 10 | Moderna Inc | MRNA | Unknown | 2.42% |
Fund Information
Net AssetsN/A
Total Holdings123
Fund FamilyUnknown